Reducing rates of inappropriately indicated proton pump inhibitor (PPI) prescription
Care Process & Redesign
National Healthcare Group Quality Improvement
National Healthcare Group
31 December 2018
Reduce overuse of non-evidence-based proton pump inhibitors (PPIs). Educational initiatives improve prescribing practices and prevent overutilization.
Year Submitted: 2018
Published Date: 31 December 2018
Tags: Care Process ＆ Redesign, Quality Improvement, Workflow Redesign, Clinical Practice Improvement, Value Based Care, Safe Care, Adverse Outcome Reduction
About this Content
Aims
Reduce overuse of non-evidence-based proton pump inhibitors (PPIs).
Background
PPI prescriptions have surged despite limited evidence of benefit, contributing to adverse effects like C. difficile infections and fractures.
Methods
Educational roadshows, deprescribing guidelines, and pharmacist-led interventions targeting inappropriate PPI prescriptions.
Results
PPI utilization reduced by 10.6%; evidence-based prescriptions increased, with better dosing practices for recommended indications.
Conclusion
Educational initiatives improve prescribing practices and prevent overutilization.
Lessons Learnt
Comprehensive stakeholder engagement is necessary for addressing systemic prescribing issues.
Keywords
Proton Pump Inhibitors, Clinical Improvement, Deprescribing, Safe Care, Process Improvement, TTSH, Evidence-Based Medicine, Polypharmacy, Adverse Outcome Reduction
Innovators' Details
Innovators' Details
Healthcare Cluster(s) | National Healthcare Group |
Organization(s) Involved | Tan Tock Seng Hospital |
Platform(s) | National Healthcare Group Quality Improvement |
Healthcare Professional Group(s) | Medical, Pharmacy |
Applicable Specialty or Discipline | Gastroenterology, Clinical Research, Pharmacology |
Project Lead(s) | Christina Tan |
Project Member(s) |
Connect with this contributor!
Christina Tan - christina_jy_tan@ttsh.com.sg